Hepatocellular Carcinoma Recurrence and Anesthesia

Completed

• Conditions: Hepatocellular Carcinoma
• Interventions: Other: Volatile anesthetics; Other: Intravenous anesthetics

• Registration Number: NCT02643173
• Lead Sponsor: Seoul National University Bundang Hospital

Brief Summary

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-09
• Study First Submitted: 2015-12-29
• Study First Submitted QC: 2015-12-29
• Study First Posted: 2015-12-31
• Primary Completion: 2019-06
• Study Completion: 2019-06
• Status Verified: 2019-11
• Last Update Submitted: 2019-11-21
• Last Update Posted: 2019-11-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 259

Inclusion Criteria

• Patients undergoing surgery due to the HCC.

Read More

Exclusion Criteria

• Patients undergoing re-operation due to the HCC.
• Patients presenting distant metastasis.
• Patients undergoing liver transplantation surgery.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Volatile	Volatile anesthetics	The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using volatile anesthetics as maintenance agents.
Intravenous	Intravenous anesthetics	The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using intravenous anesthetics as maintenance agents.

Primary Outcome Measures

Name	Time	Method
Recurrence of HCC	Postoperative 2 year

Trial Locations

Locations (1)

Seoul National University Bundang Hospital; 🇰🇷 Seongnam, Gyeonggi, Korea, Republic of